This site is intended for healthcare professionals only
The government’s move to implement longer prescription cycles on hormone replacement therapy (HRT) could have “complex consequences” for pharmacy contractors, Pharmaceutical Services Negotiating Committee (PSNC) director of pharmacy funding Mike Dent has said.
Working with NHS England and NHS Improvement, the Department of Health and Social Care (DH) will move to cut the cost of repeatable HRT prescriptions and implement longer prescription cycles for the menopausal symptom treatment, it announced last week (October 29).
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
0The National Institute for Health and Care Excellence (NICE) has proposed that people with long-term conditions – including obstructive sleep apnoea, schizophrenia and learning disabilities – are weighed annually.
0Retail trade union Usdaw has revealed that Tesco workers, including pharmacy staff directly employed by the supermarket, will see a 5.2% increase in hourly pay from this month.
1MP and pharmacist Sadik Al-Hassan has said the promised community pharmacy prescribing service is “deliverable” but not ready yet.
The Danish drugmaker has launched a “direct-to-patient” pharmacy, offering "all dose strengths of Wegovy at a reduced cost”.
A coroner has warned of the “potential dangers” of a trio of drugs, after a patient died who had been on them for four years “without concern”.
